Showing results (1421-1430 of 1,996) with videos related to

Sort By:
Pageof 200
The Lancet. Neurology|March 21, 2014
Embolic strokes of undetermined source: the case for a new clinical constructRobert G Hart, Hans-Christoph Diener, Shelagh B Coutts, et al.
The Lancet. Neurology|March 4, 2008
Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screenHylke M Blauw, Jan H Veldink, Michael A van Es, et al.
The Lancet. Neurology|February 18, 2017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort studyTomas Kalincik, J William L Brown, Neil Robertson, et al.
The Lancet. Neurology|March 23, 2017
Epileptic activity in Alzheimer's disease: causes and clinical relevanceKeith A Vossel, Maria C Tartaglia, Haakon B Nygaard, et al.
The Lancet. Neurology|March 27, 2019
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disordersDaniel Friedman, Jacqueline A French, Mauro Maccarrone
The Lancet. Neurology|March 13, 2019
Management of epilepsy in womenLinda J Stephen, Cynthia Harden, Torbjörn Tomson, et al.
The Lancet. Neurology|March 23, 2019
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Lydia D Foster, Claudia S Moy, et al.
The Lancet. Neurology|January 20, 2017
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study,
The Lancet. Neurology|July 15, 2019
Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysisJennifer Freeman, Wendy Hendrie, Louise Jarrett, et al.
The Lancet. Neurology|February 22, 2014
Neurobehavioural effects of developmental toxicityPhilippe Grandjean, Philip J Landrigan
Pageof 200